MoneyWorks4Me

Glenmark Pharmaceuticals informs about media release

21 Sep 2021 Evaluate

Glenmark Pharmaceuticals has informed that it attached media release on 21st September 2021 titled ‘Glenmark Pharmaceuticals receives ANDA approval for Clindamycin Phosphate Foam, 1%’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..